Eylea
E579609
Eylea is a widely used injectable drug for treating retinal diseases such as wet age-related macular degeneration by inhibiting vascular endothelial growth factor (VEGF).
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
biologic drug
ⓘ
ophthalmic drug ⓘ pharmaceutical drug ⓘ |
| hasAdverseEffect |
cataract
ⓘ
conjunctival hemorrhage ⓘ endophthalmitis ⓘ eye pain ⓘ increased intraocular pressure ⓘ intraocular inflammation ⓘ retinal detachment ⓘ thromboembolic events ⓘ vitreous detachment ⓘ |
| hasATCCode | S01LA05 ⓘ |
| hasContraindication |
active intraocular inflammation
ⓘ
hypersensitivity to aflibercept ⓘ ocular or periocular infection ⓘ |
| hasDosageForm | solution for injection ⓘ |
| hasGenericName | aflibercept ⓘ |
| hasIndication |
diabetic macular edema
ⓘ
macular edema following retinal vein occlusion ⓘ myopic choroidal neovascularization ⓘ neovascular age-related macular degeneration ⓘ wet age-related macular degeneration ⓘ |
| hasMechanismOfAction |
VEGF-A binding
ⓘ
placental growth factor binding ⓘ vascular endothelial growth factor inhibitor ⓘ |
| hasMolecularType | fusion protein ⓘ |
| hasPharmacologicalClass |
angiogenesis inhibitor
ⓘ
recombinant fusion protein ⓘ |
| hasRegulatoryApproval |
European Medicines Agency
NERFINISHED
ⓘ
U.S. Food and Drug Administration NERFINISHED ⓘ |
| hasRouteOfAdministration |
intraocular
ⓘ
intravitreal injection ⓘ |
| hasTherapeuticArea |
ophthalmology
ⓘ
retinal vascular disease ⓘ |
| hasYearOfFirstApproval | 2011 ⓘ |
| isAdministeredBy | ophthalmologist ⓘ |
| isAdministeredFrequency |
every 4 weeks during initial phase
ⓘ
every 8 weeks during maintenance phase ⓘ |
| isManufacturedBy | Regeneron Pharmaceuticals NERFINISHED ⓘ |
| isMarketedBy |
Bayer
NERFINISHED
ⓘ
Regeneron Pharmaceuticals NERFINISHED ⓘ |
| isUsedFor |
prevention of vision loss
ⓘ
reduction of macular edema ⓘ treatment of retinal diseases ⓘ |
| targets |
VEGF-A
NERFINISHED
ⓘ
VEGF-B NERFINISHED ⓘ placental growth factor ⓘ |
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.